GlassScriptPhysician profile
Andre K Artis
NPI 1811987688
$16,854.57
in general payments reported to CMS, 2019-2025
54 companies · $1,580 in 2025
The $1,580 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,763 · 2020: $883 · 2021: $5,239 · 2022: $1,879 · 2023: $1,367 · 2024: $1,144 · 2025: $1,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,061 · Education: $29.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,061.00 |
| Education | $29.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,411.29 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,127.59 | 2019-2025 | Wainua, Farxiga |
| Zimmer Biomet Holdings, INC. | $1,241.73 | 2021 | |
| Penumbra, INC. | $826.21 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $677.28 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $615.88 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $584.97 | 2022-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $579.56 | 2019-2024 | Xarelto |
| Livanova USA, INC. | $495.59 | 2019 | |
| Zimvie INC. | $468.00 | 2022 | |
| Endologix LLC | $430.06 | 2019-2024 | Endocross Device, Torus Stent Graft System |
| Abbott Laboratories | $329.49 | 2019-2025 | Perclose Prostyle, Cardiomems, Mitraclip |
| Amgen INC. | $289.24 | 2019-2022 | |
| Boston Scientific Corporation | $249.01 | 2022-2025 | Watchman Flx, Ekosonic, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $240.56 | 2023-2025 | Camzyos, Eliquis |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $229.43 | 2022-2025 | Wegovy, Ozempic |
| Chiesi USA, INC. | $228.83 | 2019-2025 | Kengreal, Cleviprex |
| Pfizer INC. | $223.91 | 2019-2025 | |
| Scpharmaceuticals INC. | $217.08 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $194.37 | 2022-2025 | Assure Wcd |
| Cordis US Corp. | $189.46 | 2024-2025 | Mynx Control Venous, Precise Pro Rx, Mynx Venous Vcd |
| Endotronix, INC. | $158.28 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Alnylam Pharmaceuticals INC. | $138.31 | 2020-2024 | Onpattro, Givlaari |
| Inari Medical, INC. | $137.25 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $129.42 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $110.62 | 2022-2023 | Fluency Endovascular Stent Graft |
| Itamar Medical INC | $104.63 | 2022-2023 | Watchpatone |
| Astellas Pharma US INC | $101.09 | 2019-2022 | |
| Abiomed | $97.93 | 2023-2024 | Impella |
| Esperion Therapeutics, INC. | $96.04 | 2021-2024 | Nexletol |
| Medtronic, INC. | $83.22 | 2021-2024 | Corevalve Evolut R, In.Pact Av |
| Becton, Dickinson and Company | $78.28 | 2025 | Hemosphere |
| Biotronik INC. | $72.15 | 2023 | Orsiro Mission |
| Lexicon Pharmaceuticals, INC. | $71.45 | 2023-2024 | Inpefa |
| Orapharma, A Division of Bausch Health US, LLC | $66.12 | 2021-2022 | |
| Cvrx, INC. | $53.73 | 2024 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $53.67 | 2021 | |
| Getinge USA Sales, LLC | $53.50 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.91 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $41.83 | 2019 | |
| Edwards Lifesciences Corporation | $40.82 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cardiovascular Systems INC. | $35.42 | 2019 | |
| Medicomp INC | $33.87 | 2024 | Telepatch Cardiac Monitor |
| Veryan Medical Incorporated | $24.60 | 2022 | |
| Lundbeck LLC | $23.12 | 2019 | |
| Surmodics, INC. | $22.26 | 2022 | |
| Philips North America LLC | $18.00 | 2022 | |
| Atricure, INC. | $17.54 | 2023 | |
| Nuwellis, INC. | $16.40 | 2021 | |
| Heartflow, INC. | $16.27 | 2024 | |
| Vifor Pharma, INC. | $16.25 | 2019 | |
| Lilly USA, LLC | $15.47 | 2024 | Mounjaro, Zepbound |
| Amryt Pharma Holdings LTD | $13.34 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Artis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.